Industry groups call for better alignment between decentralized, centralized trials

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and Development